The role of B cells and humoral immunity in mycobacterium Tuberculosis infection

Advances in Experimental Medicine and Biology

Volumn 783, Issue , 2013, Pages 225-250

  Kozakiewicz, Lee ^a   Phuah, Jiayao ^b   Flynn, Joanne ^b   Chan, John ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; Antigen presentation; B cells; Cytokine production; Cytokines; Fcc receptors; Granuloma; Humoral immunity; Immunopathology; Macrophages; Myocobacterium Tuberculosis; Neutrophils; T cell responses

Indexed keywords

ARABINOMANNAN; BCG VACCINE; FC RECEPTOR; IMMUNOGLOBULIN; INTERLEUKIN 10; MYCOBACTERIUM ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; BACTERIUM ANTIBODY; LYMPHOKINE;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; GERMINAL CENTER; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; INTRACELLULAR KILLING; MACROPHAGE; MULTIDRUG RESISTANCE; NONHUMAN; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; REINFECTION; TUBERCULOSIS; ANIMAL; ANTIGEN PRESENTING CELL; BIOLOGICAL MODEL; BIOSYNTHESIS; IMMUNOLOGY; LATENT TUBERCULOSIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MICROBIOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; PATHOLOGY; PRIMATE; REVIEW; SPECIES DIFFERENCE; T LYMPHOCYTE SUBPOPULATION; TUBERCULOMA;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTE SUBSETS; GERMINAL CENTER; HUMANS; IMMUNITY, CELLULAR; LATENT TUBERCULOSIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COOPERATION; LYMPHOKINES; MACROPHAGES; MICE; MODELS, IMMUNOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; PRIMATES; RECEPTORS, IGG; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS; TUBERCULOMA; TUBERCULOSIS; TUBERCULOSIS VACCINES;

MLCS; MLOWN;

EID: 84879545297     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-6111-1_12     Document Type: Article

References (195)

1. World Health Organization (2009) Global Tuberculosis control: epidemiology, strategy, financing. WHO Report, 2009
2. Flynn JL, Chan J (2003) Immune evasion by Mycobacterium Tuberculosis: living with the enemy. Curr Opin Immunol 15(4):450-455
3. Cooper AM (2003) Cell-mediated immune responses in Tuberculosis. Annu Rev Immunol X 27:393-422
4. North RJ, Jung YJ (2004) Immunity to Tuberculosis. Annu Rev Immunol 22:599-623
5. Kaufmann SH (2002) Protection against Tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis 61(suppl 2):ii54-ii58
6. Sperber SJ, Gornish N (1992) Reactivation of Tuberculosis during therapy with corticosteroids. Clin Infect Dis 15(6):1073-1074
7. Keane J et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alphaneutralizing agent. N Engl J Med 345(15):1098-1104
8. Selwyn PA et al (1989) A prospective study of the risk of Tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320(9):545-550
9. Flynn JL (2004) Immunology of Tuberculosis and implications in vaccine development. Tuberculosis 84(1-2):93-101
10. Dye C (2009) Doomsday postponed? Preventing and reversing epidemics of drug-resistant Tuberculosis. Nat Rev Microbiol 7(1):81-87
11. Flynn JL, Chan J (2001) Immunology of Tuberculosis. Annu Rev Immunol 19:93-129
12. Kaufmann SH (2010) Future vaccination strategies against Tuberculosis: thinking outside the box. Immunity 33(4):567-577
13. Kaufmann SH (2001) How can immunology contribute to the control of Tuberculosis? Nat Rev Immunol 1(1):20-30
14. Colditz GA et al (1994) Efficacy of BCG vaccine in the prevention of Tuberculosis. Metaanalysis of the published literature. J Am Med Assoc 271(9):698-702
15. Corbett EL et al (2003) The growing burden of Tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163(9):1009-1021
16. Dye C et al (1999) Consensus statement. Global burden of Tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. J Am Med Assoc 282(7):677-686
17. Andersen P (2007) Tuberculosis vaccinesan update. Nat Rev Microbiol 5(7):484-487
18. Kaufmann SH (2007) The contribution of immunology to the rational design of novel antibacterial vaccines. Nat Rev Microbiol 5(7):491-504
19. Casadevall A, Pirofski LA (2012) A new synthesis for antibody-mediated immunity. Nat Immunol 13(1):21-82
20. Glatman-Freedman A, Casadevall A (1998) Serum therapy for Tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium Tuberculosis. Clin Microbiol Rev 11(3):514-532
21. Maglione PJ, Chan J (2009) How B cells shape the immune response against Mycobacterium Tuberculosis. Eur J Immunol 39(3):676-686
22. Kumararatne DS (1997) Tuberculosis and immunodeficiency of mice and men. Clin Exp Immunol 107(1):11-14
23. Kaufmann SH (2008) Elie Metchnikoff's and Paul Ehrlich's impact on infection biology. Microbes Infect/Institut Pasteur 10(14-15):1417-1419
24. Silverstein AM (2003) Darwinism and immunology: from Metchnikoff to Burnet. Nat Immunol 4(1):3-6
25. Tan SY, Dee MK (2009) Elie Metchnikoff (1845-1916): discoverer of phagocytosis. Singap Med J 50(5):456-457
26. Collins FM (1978) Cellular antimicrobial immunity. CRC Crit Rev Microbiol 7(1):27-91
27. Mackaness GB (1962) Cellular resistance to infection. J Exp Med 116:381-406
28. Casadevall A (2003) Antibody-mediated immunity against intracellular pathogens: twodimensional thinking comes full circle. Infect Immun 71(8):4225-4228
29. Casadevall A, Pirofski LA (2006) A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immunol 91:1-44
30. Pulendran B, Ahmed R (2011) Immunological mechanisms of vaccination. Nat Immunol 12(6):509-517
31. Seder RA, Hill AV (2000) Vaccines against intracellular infections requiring cellular immunity. Nature 406(6797):793-798
32. Culkin SJ, Rhinehart-Jones T, Elkins KL (1997) A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol 158(7):3277-3284
33. Langhorne J et al (1998) A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc Natl Acad Sci U S A 95(4):1730-1734
34. Li JS, Winslow GM (2003) Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells. Infect Immun 71(8):4229-4237
35. Mastroeni P et al (2000) Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 68(1):46-53
36. Su H et al (1997) Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun 65(6):1993-1999
37. Woelbing F et al (2006) Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med 203(1):177-188
38. Yang X, Brunham RC (1998) Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J Immunol 161(3):1439-1446
39. Grosset J (2003) Mycobacterium Tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrob Agents Chemother 47(3):833-836
40. Hoff DR et al (2011) Location of intra- and extracellular M. Tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment. PLoS ONE 6(3):e17550
41. Wayne LG, Sohaskey CD (2001) Nonreplicating persistence of Mycobacterium Tuberculosis. Annu Rev Microbiol 55:139-163
42. Fujinami RS, Oldstone MB (1979) Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature 279(5713):529-530
43. Griffin DE, Metcalf T (2011) Clearance of virus infection from the CNS. Curr Opin Virol 1(3):216-221
44. Metcalf TU, Griffin DE (2011) Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system. J Virol 85(21):11490-11501
45. Yanase K et al (1994) A subgroup of murine monoclonal anti-deoxyribonucleic acid antibodies traverse the cytoplasm and enter the nucleus in a time-and temperaturedependent manner. Lab Investig J Tech Methods Pathol 71(1):52-60
46. Mazanec MB, Coudret CL, Fletcher DR (1995) Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 69(2):1339-1343
47. Mazanec MB et al (1992) Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A 89(15):6901-6905
48. Lund FE, Randall TD (2010) Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat Rev Immunol 10(4):236-247
49. Elkins KL, Bosio CM, Rhinehart-Jones TR (1999) Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain. Infect Immun 67(11):6002-6007
50. Esser MT et al (2003) Memory T cells and vaccines. Vaccine 21(5-6):419-430
51. Linton PJ, Harbertson Bradley LM (2000) A critical role for B cells in the development of memory CD4 cells. J Immunol 165(10):5558-5565
52. Lund FE et al (2006) B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol 176(10):6147-6154
53. Schultze JL et al (1999) Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med 189(1):1-12
54. Shen H et al (2003) A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes. J Immunol 170(3):1443-1451
55. Stephens R, Langhorne J (2006) Priming of CD4+ T cells and development of CD4+ T cell memory; lessons for malaria. Parasite Immunol 28(1-2):25-30
56. Whitmire JK et al (2009) Requirement of B cells for generating CD4+ T cell memory. J Immunol 182(4):1868-1876
57. Wojciechowski W et al (2009) Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity 30(3):421-433
58. Igietseme JU et al (2004) Antibody regulation of T cell immunity: implications for vaccine strategies against intracellular pathogens. Expert Rev Vaccines 3(1):23-34
59. Rawool DB et al (2008) Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis. J Immunol 180(8):5548-5557
60. Weber SE, Tian H, Pirofski LA (2011) CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice. J Immunol 186(1):432-442
61. van Schaik SM, Abbas AK (2007) Role of T cells in a murine model of Escherichia coli sepsis. Eur J Immunol 37(11):3101-3110
62. Vinuesa CG et al (2005) Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol 5(11):853-865
63. Gray D, Gray M, Barr T (2007) Innate responses of B cells. Eur J Immunol 37(12):3304-3310
64. Czuczman MS, Gregory SA (2010) The future of CD20 monoclonal antibody therapy in Bcell malignancies. Leuk Lymphoma 51(6):983-994
65. Townsend MJ, Monroe JG, Chan AC (2010) B-cell targeted therapies in human autoimmune diseases: an updated perspective. Immunol Rev 237(1):264-283
66. Castiglioni P, Gerloni M, Zanetti M (2004) Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity mediated by central memory CD8 T cells. Vaccine 23(5):699-708
67. Heit A et al (2004) CpG-DNA aided cross-priming by cross-presenting B cells. J Immunol 172(3):1501-1507
68. Jiang W et al (2011) Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells. J Immunol 186(4):2080-2086
69. Asano MS, Ahmed R (1996) CD8 T cell memory in B cell-deficient mice. J Exp Med 183(5):2165-2174
70. Di Rosa F, Matzinger P (1996) Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. J Exp Med 183(5):2153-2163
71. Britton S, Mitchison NA, Rajewsky K (1971) The carrier effect in the secondary response to hapten-protein conjugates. IV. Uptake of antigen in vitro and failure to obtain cooperative induction in vitro. Eur J Immunol 1(2):65-68
72. Mitchison NA (2004) T-cell-B-cell cooperation. Nat Rev Immunol 4(4):308-312
73. Lanzavecchia A (1985) Antigen-specific interaction between T and B cells. Nature 314(6011):537-539
74. Lanzavecchia A (1990) Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 8:773-793
75. Vascotto F et al (2007) Antigen presentation by B lymphocytes: how receptor signaling directs membrane trafficking. Curr Opin Immunol 19(1):93-98
76. Itano AA, Jenkins MK (2003) Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol 4(8):733-739
77. Cassell DJ, Schwartz RH (1994) A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J Exp Med 180(5):1829-1840
78. Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449(7161):419-426
79. Weber MS et al (2010) B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol 68(3):369-383
80. Liu Y et al (1995) Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Int Immunol 7(8):1353-1362
81. Kurt-Jones EA et al (1988) The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol 140(11):3773-3778
82. Rodriguez-Pinto D, Moreno J (2005) B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner. Eur J Immunol 35(4):1097-1105
83. Rodriguez-Pinto D (2005) B cells as antigen presenting cells. Cell Immunol 238(2):67-75
84. Catron DM et al (2004) Visualizing the first 50 hr of the primary immune response to a soluble antigen. Immunity 21(3):341-347
85. Pape KA et al (2007) The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity 26(4):491-502
86. Helgeby A et al (2006) The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells. J Immunol 176(6):3697-3706
87. Hon H et al (2005) B lymphocytes participate in cross-presentation of antigen following gene gun vaccination. J Immunol 174(9):5233-5242
88. Andersen CS et al (2007) The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium Tuberculosis. Infect Immun 75(1):408-416
89. McClellan KB et al (2006) Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathog 2(6):e58
90. Schultze JL, Grabbe S, von Bergwelt-Baildon MS (2004) DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy. Trends Immunol 25(12):659-664
91. Chan OT et al (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189(10):1639-1648
92. Chen X, Jensen PE (2007) Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3 + CD4 T cells. J Immunol 179(4):2046-2050
93. Tsitoura DC et al (2002) Critical role of B cells in the development of T cell tolerance to aeroallergens. Int Immunol 14(6):659-667
94. Hackett CJ et al (2007) Immunology research: challenges and opportunities in a time of budgetary constraint. Nat Immunol 8(2):114-117
95. Pepper M, Jenkins MK (2011) Origins of CD4(+) effector and central memory T cells. Nat Immunol 12(6):467-471
96. Liu Y (1992) Janeway CA Jr M (1992) Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. Proc Natl Acad Sci U S A 89(9):3845-3849
97. Janeway CA Jr (2002) A trip through my life with an immunological theme. Annu Rev Immunol 20:1-28
98. Sharpe AH, Freeman GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol 2(2):116-126
99. Medzhitov R, Janeway CA Jr (2000) Innate immunity. N Engl J Med 343(5):338-344
100. Dhodapkar KM et al (2005) Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc Natl Acad Sci U S A 102(8):2910-2915
101. Kalergis AM, Ravetch JV (2002) Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med 195(12):1653-1659
102. Mauri C et al (2003) Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197(4):489-501
103. Mizoguchi A et al (2007) Dependence of intestinal granuloma formation on unique myeloid DC-like cells. J Clin Investig 117(3):605-615
104. Rafiq K, Bergtold A, Clynes R (2002) Immune complex-mediated antigen presentation induces tumor immunity. J Clin Investig 110(1):71-79
105. Sugimoto K et al (2007) Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation. Gastroenterology 133(1):124-136
106. Bayry J et al (2004) Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci U S A 101(39):14210-14215
107. Bayry J et al (2005) Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol 175(1):15-20
108. Harris DP et al (2000) Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 1(6):475-482
109. Moulin V et al (2000) B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med 192(4):475-482
110. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (). Annu Rev Immunol 28:445-489
111. Lund FE (2008) Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 20(3):332-338
112. Lund FE et al (2005) Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr Dir Autoimmun 8:25-54
113. Mosmann T (2000) Complexity or coherence? Cytokine secretion by B cells. Nat Immunol 1(6):465-466
114. Mauri C, Bosma A (2012) Immune regulatory function of B cells. Annu Rev Immunol 30:221-241
115. Harris DP et al (2005) Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor. J Immunol 174(11):6781-6790
116. Wagner M et al (2004) IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol 172(2):954-963
117. Johansson-Lindbom B, Ingvarsson S, Borrebaeck CA (2003) Germinal centers regulate human Th2 development. J Immunol 171(4):1657-1666
118. DiLillo DJ, Matsushita T, Tedder TF (2010) B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 1183:38-57
119. Amigorena S, Bonnerot C (1999) Fc receptors for IgG and antigen presentation on MHC class I and class II molecules. Semin Immunol 11(6):385-390
120. Nimmerjahn F, Ravetch JV (2006) Fcgamma receptors: old friends and new family members. Immunity 24(1):19-28
121. Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19:275-290
122. Desai DD et al (2007) Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J Immunol 178(10):6217-6226
123. Bandukwala HS et al (2007) Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation. J Exp Med 204(8):1875-1889
124. Nimmerjahn F, Ravetch JV (2005) Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310(5753):1510-1512
125. Shi J, McIntosh RS, Pleass RJ (2006) Antibody- and Fc-receptor-based therapeutics for malaria. Clin Sci (Lond) 110(1):11-19
126. Park-Min KH et al (2007) FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin. Immunity 26(1):67-78
127. Moore T et al (2003) Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J Infect Dis 188(4):617-624
128. Huber VC et al (2001) Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol 166(12):7381-7388
129. Kima PE et al (2000) Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med 191(6):1063-1068
130. Menager N et al (2007) Fcgamma receptors are crucial for the expression of acquired resistance to virulent Salmonella enterica serovar Typhimurium in vivo but are not required for the induction of humoral or T-cell-mediated immunity. Immunology 120(3):424-432
131. Uppington H et al (2006) Effect of immune serum and role of individual Fcgamma receptors on the intracellular distribution and survival of Salmonella enterica serovar Typhimurium in murine macrophages. Immunology 119(2):147-158
132. Yoneto T et al (2001) A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection. J Immunol 166(10):6236-6241
133. Yuan R et al (1998) Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med 187(4):641-648
134. Maglione PJ et al (2008) Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium Tuberculosis infection. J Immunol 180(5):3329-3338
135. Klimstra WB et al (2005) Targeting Sindbis virus-based vectors to Fc receptor-positive cell types. Virology 338(1):9-21
136. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5(12):953-964
137. Martinez FO et al (2008) Macrophage activation and polarization. Front Biosci 13:453-461
138. Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. J Immunol 181(6):3733-3739
139. Mantovani A et al (2008) Cancer-related inflammation. Nature 454(7203):436-444
140. Pollard JW (2009) Trophic macrophages in development and disease. Nat Rev Immunol 9(4):259-270
141. Wong SC et al (2010) Macrophage polarization to a unique phenotype driven by B cells. Eur J Immunol 40(8):2296-2307
142. Tsai MC et al (2006) Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 8(2):218-232
143. Halstead SB et al (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 10(10):712-722
144. Halstead SB, Chow JS, Marchette NJ (1973) Immunological enhancement of dengue virus replication. Nat New Biol 243(122):24-26
145. Mahalingam S, Lidbury BA (2002) Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc Natl Acad Sci U S A 99(21):13819-13824
146. Teitelbaum R et al (1998) A mAb recognizing a surface antigen of Mycobacterium Tuberculosis enhances host survival. Proc Natl Acad Sci U S A 95(26):15688-15693
147. Calmette A (ed) (1923) Tubercle bacillus infection and Tuberculosis in man and animals. The Williams & Wilkins Co., Baltimore, pp 603-623
148. Porter R (ed) (1997) The greatest benefit to mankind: a medical history of hummanity. WW Norton & Company, New York
149. Glatman-Freedman A (2006) The role of antibody-mediated immunity in defense against Mycobacterium Tuberculosis: advances toward a novel vaccine strategy. Tuberculosis 86(3-4):191-197
150. Hamasur B et al (2004) A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium Tuberculosis. Clin Exp Immunol 138(1):30-38
151. Pethe K et al (2001) The heparin-binding haemagglutinin of M. Tuberculosis is required for extrapulmonary dissemination. Nature 412(6843):190-194
152. Reljic R et al (2006) Intranasal IFNgamma extends passive IgA antibody protection of mice against Mycobacterium Tuberculosis lung infection. Clin Exp Immunol 143(3):467-473
153. Williams A et al (2004) Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology 111(3):328-333
154. Guirado E et al (2006) Passive serum therapy with polyclonal antibodies against Mycobacterium Tuberculosis protects against post-chemotherapy relapse of Tuberculosis infection in SCID mice. Microbes Infect 8(5):1252-1259
155. Roy E et al (2005) Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium Tuberculosis infection in mice. Infect Immun 73(9):6101-6109
156. Hamasur B et al (2003) Mycobacterium Tuberculosis arabinomannan-protein conjugates protect against Tuberculosis. Vaccine 21(25-26):4081-4093
157. Flynn JL (2006) Lessons from experimental Mycobacterium Tuberculosis infections. Microbes Infect/Institut Pasteur 8(4):1179-1188
158. Young D (2009) Animal models of Tuberculosis. Eur J Immunol 39(8):2011-2014
159. Boes M (2000) Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37(18):1141-1149
160. Ehrenstein MR, Notley CA (2010) The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 10(11):778-786
161. Fagarasan S, Honjo T (2000) T-Independent immune response: new aspects of B cell biology. Science 290(5489):89-92
162. Lopes-Carvalho T, Foote J, Kearney JF (2005) Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol 17(3):244-250
163. Lopes-Carvalho T, Kearney JF (2004) Development and selection of marginal zone B cells. Immunol Rev 197:192-205
164. Weill JC, Weller S, Reynaud CA (2009) Human marginal zone B cells. Annu Rev Immunol 27:267-285
165. Aurora AB et al (2005) Immune complex-dependent remodeling of the airway vasculature in response to a chronic bacterial infection. J Immunol 175(10):6319-6326
166. Maglione PJ, Xu J, Chan J (2007) B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium Tuberculosis. J Immunol 178(11):7222-7234
167. Clynes R (2007) Protective mechanisms of IVIG. Curr Opin Immunol 19(6):646-651
168. Fauci AS et al (2008) HIV vaccine research: the way forward. Science 321(5888):530-532
169. Junqueira-Kipnis AP et al (2005) Interleukin-10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium Tuberculosis. Immunology 115(2):246-252
170. Moore KW et al (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765
171. Rutella S, Danese S, Leone G (2006) Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108(5):1435-1440
172. Mizoguchi A, Bhan AK (2006) A case for regulatory B cells. J Immunol 176(2):705-710
173. Olson TS et al (2004) Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J Clin Investig 114(3):389-398
174. Redford PS, Murray PJ, O'Garra A (2011) The role of IL-10 in immune regulation during M. Tuberculosis infection. Mucosal Immunol 4(3):261-270
175. Gallo P, Goncalves R, Mosser DM (2010) The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production. Immunol Lett 133(2):70-77
176. Flynn JL, Chan J, Lin PL (2011) Macrophages and control of granulomatous inflammation in Tuberculosis. Mucosal Immunol 4(3):271-278
177. Willcocks LC, Smith KG, Clatworthy MR (2009) Low-affinity Fcgamma receptors, autoimmunity and infection. Expert Rev Mol Med 11:e24
178. Boruchov AM et al (2005) Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Investig 115(10):2914-2923
179. Bosio CM, Gardner D, Elkins KL (2000) Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium Tuberculosis: delay in dissemination and development of lung pathology. J Immunol 164(12):6417-6425
180. Dheda K et al (2005) Lung remodeling in pulmonary Tuberculosis. J Infect Dis 192(7):1201-1209
181. Ulrichs T et al (2004) Human tuberculous granulomas induce peripheral lymphoid folliclelike structures to orchestrate local host defence in the lung. J Pathol 204(2):217-228
182. Moraes TJ, Zurawska JH, Downey GP (2006) Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol 13(1):21-27
183. Eruslanov EB et al (2005) Neutrophil responses to Mycobacterium Tuberculosis infection in genetically susceptible and resistant mice. Infect Immun 73(3):1744-1753
184. Gonzalez-Juarrero M et al (2001) Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium Tuberculosis. Infect Immun 69(3):1722-1728
185. Turner J et al (2001) The progression of chronic Tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4. Exp Gerontol 36(3):537-545
186. Manzo A et al (2005) Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol 35(5):1347-1359
187. Serafini B et al (2004) Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14(2):164-174
188. Moyron-Quiroz JE et al (2004) Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 10(9):927-934
189. Shomer NH et al (2003) Helicobacter-induced chronic active lymphoid aggregates have characteristics of tertiary lymphoid tissue. Infect Immun 71(6):3572-3577
190. Bussiere FI et al (2006) Low multiplicity of infection of Helicobacter pylori suppresses apoptosis of B lymphocytes. Cancer Res 66(13):6834-6842
191. Spera JM et al (2006) A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc Natl Acad Sci U S A 103(44):16514-16519
192. Capuano SV 3rd et al (2003) Experimental Mycobacterium Tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. Tuberculosis infection. Infect Immun 71(10):5831-5844
193. Flynn JL et al (2003) Non-human primates: a model for Tuberculosis research. Tuberculosis 83(1-3):116-118
194. Kahnert A et al (2007) Mycobacterium Tuberculosis triggers formation of lymphoid structure in murine lungs. J Infect Dis 195(1):46-54
195. Moyron-Quiroz JE et al (2006) Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 25(4):643-654